Best practice guidelines for melanoma care go digital
28 October 2016
Health professionals treating melanoma patients have access to the first in a series of new, wiki-based clinical recommendations with the launch of electronic clinical practice guidelines for the diagnosis and management of melanoma.
The release of the renewed resource, in Sydney at the Australasian Melanoma Conference, marks the first time a melanoma management guideline has been published in a wiki format for continual electronic update.
The first in a comprehensive series of updated melanoma guidelines, it provides evidence-based recommendations on the recognition of melanomas, biopsy of suspicious lesions, when to perform sentinel node biopsy and margins for radical excision of primary melanomas.
The guidelines are being developed in partnership by Cancer Council Australia and Melanoma Institute Australia, with additional funding from the Skin Cancer College Australasia.
Chair of the project’s expert working group, Professor John Thompson AO, said the guidelines were the result of an exhaustive systematic review and public consultation process and were being launched at a time of rapid change in the management of melanoma.
“Things are moving quickly in melanoma management,” Professor Thompson said. “A comprehensive systematic review of the evidence was timely.
“The publication of updated guidelines on Cancer Council Australia’s wiki platform means they can now be continually reviewed as new evidence becomes available. Using wiki software also means that we can publish guidelines in sections as they are finalised, rather than waiting for large paperbased volumes to be printed and distributed.”
One of the most significant changes in recommended practice in the new guideline was a strengthening of the evidence for sentinel node biopsy.
“The review found new evidence to support the use of sentinel node biopsy to accurately stage melanoma,” Professor Thompson said. “This is particularly important, given the advent of new effective but high-cost drugs that may be of value in appropriately staged patients.”
The guidelines will cover prevention, diagnosis, management and follow-up as well as special population groups such as children and pregnant women. The full set of guidelines is expected to be completed and published by early 2018.
The new set of guidelines are available online.
Read more on our Research Blog.
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'